NK007 helps in mitigating paclitaxel resistance through p38MAPK activation and HK2 degradation in ovarian cancer

Journal of Cellular Physiology
Zhenhua LiHengwen Yang

Abstract

Ovarian cancer resistance to available medicines is a huge challenge in dire need of a solution, which makes its recurrence and mortality rate further exacerbated. A promising approach to overcome chemoresistance is drug screening from natural products. Here, we report that NK007, a (±)-tylophorine malate isolated from the Asclepiadaceae family, selectively inhibited the proliferation of A2780 and A2780 (Taxol) cells and migration of paclitaxel-sensitive and -resistant ovarian cancer cells. Interestingly, the decline of cell viability, including cell multiplication, clonality, and migration capacity was independent on cell apoptosis. At the molecular level, NK007 considerably induced G1/S arrest and upregulated the expression of phospho-p38 mitogen-activated protein kinase (p-p38MAPK). In addition, hexokinase 2 (HK2) protein degradation was considerably elevated in the presence of NK007, which resulted in the reduction of oxygen consumption rate and extracellular acidification rate. Altogether, our results indicate that NK007, an analog of tylophorine, can overcome paclitaxel (PTX) resistance through p38MAPK activation and HK2 degradation. As an effective, alternative antiresistance agent, NK007 exhibits a promising potential t...Continue Reading

References

Apr 29, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J S BerekP H Willemse
Sep 20, 2007·Expert Opinion on Drug Safety·Neena I MarupudiHenry Brem
Jan 23, 2009·International Journal of Biological Sciences·Tina M Thornton, Mercedes Rincon
Dec 17, 2009·Journal of Agricultural and Food Chemistry·Kailiang WangQingmin Wang
Dec 19, 2009·The Journal of Biological Chemistry·Yongjun FanWei-Xing Zong
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Parisa Fathi RezaeiEbrahim Azizi
Jul 13, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Katrina F TriversJuan L Rodriguez
Oct 15, 2013·Cancer Discovery·Susana Ros, Almut Schulze
Feb 25, 2014·Advances in Experimental Medicine and Biology·Brian K Kennedy, Juniper K Pennypacker
Mar 4, 2014·Gynecologic Oncology·K StålbergH Kieler
May 3, 2014·Journal of Neuro-oncology·Shabnam PakneshanBahman Jabbari
Jun 6, 2014·Journal of Immunology Research·Glauben LandskronMarcela A Hermoso
Jun 16, 2015·Autophagy·Valerie P Tan, Shigeki Miyamoto
Sep 2, 2015·The Journal of Cell Biology·Hong-Guang XiaHelin Vakifahmetoglu-Norberg
Nov 17, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yanyan MaXiaoyan Wang
Feb 15, 2017·American Journal of Reproductive Immunology : AJRI·Elizabeth A Bonney
Apr 22, 2017·Cell Death and Differentiation·Kaori KanemaruKiyoko Fukami
Jun 14, 2017·Nature·Haizhen WangPiotr Sicinski
Apr 26, 2018·Nature Reviews. Cancer·Frederick A DickNicholas J Dyson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.